MARSHALL WACE, LLP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 203 filers reported holding IMMUNOMEDICS INC in Q2 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$13,709,000
+201.2%
161,222
+25.5%
0.09%
+175.0%
Q2 2020$4,552,000
-27.7%
128,452
-56.8%
0.03%
-25.6%
Q4 2019$6,295,000
-5.9%
297,513
-41.0%
0.04%
-18.9%
Q3 2019$6,687,000
-19.9%
504,208
-16.3%
0.05%
-23.2%
Q2 2019$8,350,000
+109.1%
602,116
+115.1%
0.07%
+68.3%
Q4 2018$3,993,000
+2221.5%
279,917
+2272.2%
0.04%
+485.7%
Q1 2018$172,000
-93.5%
11,800
-98.6%
0.01%
-72.0%
Q4 2015$2,631,000857,0620.02%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q2 2018.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders